Alzheimer's disease is associated with impairments in emotional communication including
comprehension and production of facial emotional expressions, comprehension of affective …

Alzheimer's Disease (AD) exerts a significant worldwide impact. An estimated 44 million
individuals currently live with this Major Neurocognitive Disorder. There are about 6.2 million …

Cannabis sativa is a medicinal plant that has been known for years and is used as an
Ayurvedic medicine. This plant has great potential in treating various types of brain …

Cannabis use has risen dramatically in recent years due to global decriminalization and a
resurgence in the interest of potential therapeutic benefits. While emerging research is …

Metformin, a widely prescribed medication for type 2 diabetes, has garnered increasing
attention for its potential neuroprotective properties due to the growing demand for …

The debate on the use of cannabinoids for therapeutic purposes is constantly on the rise.
This overview aimed to map the evidence on the therapeutic effects of cannabis derivatives …

Inflammatory bowel diseases (IBD) are characterized by a chronic and recurrent
gastrointestinal condition, including mainly ulcerative colitis (UC) and Crohn's disease (CD) …

Background and Objective: Alzheimer's disease (AD) is a progressive neurodegenerative
disorder, that is, characterized by cognitive decline. To date, there are no effective …

Agitation is a common neuropsychiatric symptom of Alzheimer's disease (AD) that greatly
impacts quality of life and amplifies caregiver burden. Agitation in AD may be associated …

THC has been used as a promising treatment approach for neurological disorders, but the
highly psychoactive effects have largely warned off many scientists from pursuing it further …